Table 2.
25-OH-Vitamin Da | Intact PTHa | Phosphorusa | Calciuma | |
---|---|---|---|---|
β (95% CI) P value | β (95% CI) P value | β (95% CI) P value | β (95% CI) P value | |
Model 1 unadjusted | −2.86 (−4.38, −1.31) <0.001 | 3.04 (1.42, 4.68) <0.001 | −2.37 (−3.90, −0.81) <0.001 | 0.52 (−1.01, 2.08) 0.51 |
Model 2b | −2.05 (−3.65, −0.42) 0.01 | 2.70 (1.09, 4.34) 0.001 | −1.86 (−3.46, −0.25) 0.02 | 0.45 (−1.11, 2.04) 0.57 |
Model 3c | −0.93 (−2.57, 0.73) 0.27 | 1.43 (−0.22, 3.11) 0.09 | −2.02 (−3.63, −0.38) 0.02 | −0.16 (−1.75, 1.46) 0.85 |
Model 4d | −0.86 (−2.46, 0.77) 0.30 | 1.00 (−0.61, 2.64) 0.23 | −1.77 (−3.35, −0.17) 0.03 | −0.76 (−2.31, 0.82) 0.35 |
There are 3 participants missing vitamin D for a total of 2,266, 1 participant missing PTH for a total of 2,268, and 7 participants missing calcium for a total of 2,262.
25 (OH) vitamin D, 25-hydroxyvitamin D; BMI, body mass index; CI, confidence interval; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PTH, parathyroid hormone; SBP, systolic blood pressure.
Per s.d. greater (25-OH-vitamin D, per 11.8 μg/l greater; intact PTH per 27.7 pg/ml greater, phosphorus per 0.48 mg/dl greater, and calcium per 0.43 mg/dl).
Age, sex, race/ethnicity, field center, and season at Y2 exam.
Model 2 plus eGFR, BMI, smoking, physical activity, diabetes, LDL, HDL, triglycerides, and lipid medication use.
Model 3 plus SBP, DBP, and antihypertensive medication use.